Nuvation Bio Stock: A Strong Company Now Fairly Priced (NYSE:NUVB)

I began building my position in Nuvation Bio ( NUVB ) earlier this summer at roughly $2.50 per share. Back then, I concluded the market severely underpriced the value of Ibtrozi, an agent treating ROS1-positive NSCLC, and assigned almost noI am a corporate lawyer with an MBA and a long-standing interest in value investing. After spending 7 years practicing at several prestigious Wall Street and Silicon Valley law firms as a corporate transactional lawyer, I founded and have been operating my own boutique la ...